These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33854800)

  • 41. [Infection in elderly leukemic patients].
    Kikukawa M; Ishida Y; Kuramoto K; Yoshida A; Tsutsumi H; Hirai M; Kumakawa T; Mori M
    Nihon Ronen Igakkai Zasshi; 1996 Jan; 33(1):17-21. PubMed ID: 8868121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
    Alrstom A; Alsuliman T; Daher N; Abouharb R
    Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Epidemiology of febrile neutropenia in patients with hematological disease-a prospective multicentre survey in China].
    Yan CH; Xu T; Zheng XY; Sun J; Duan XL; Gu JL; Zhao CL; Zhu J; Wu YH; Wu DP; Hu JD; Huang H; Jiang M; Li J; Hou M; Wang C; Shao ZH; Liu T; Hu Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):177-82. PubMed ID: 27033752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
    Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?
    Gedik H; Simşek F; Kantürk A; Yildirmak T; Arica D; Aydin D; Demirel N; Yokuş O
    Ther Clin Risk Manag; 2014; 10():743-52. PubMed ID: 25258539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile].
    Rabagliati B R; Fuentes L G; Orellana U E; Oporto C J; Domínguez M I; Benítez G R; Aedo C I; Ramos G G; Garrido S M; García C P
    Rev Chilena Infectol; 2009 Apr; 26(2):106-13. PubMed ID: 19621141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients.
    Ram R; Farbman L; Leibovici L; Raanani P; Yeshurun M; Vidal L; Gafter-Gvili A; Peck A; Shpilberg O; Paul M
    Int J Antimicrob Agents; 2012 Aug; 40(2):123-6. PubMed ID: 22727772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.
    Trehan A; Totadri S; Gautam V; Bansal D; Ray P
    Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.
    Bakhshi S; Padmanjali KS; Arya LS
    Pediatr Hematol Oncol; 2008 Jun; 25(5):385-92. PubMed ID: 18569840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience.
    Özdemir N; Tüysüz G; Çelik N; Yantri L; Erginöz E; Apak H; Özkan A; Yıldız İ; Celkan T
    Turk Pediatri Ars; 2016 Jun; 51(2):79-86. PubMed ID: 27489464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
    Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
    Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
    BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey.
    Özdemir ZC; Koç A; Ayçiçek A
    Turk J Pediatr; 2016; 58(1):47-53. PubMed ID: 27922236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
    Wananukul S; Nuchprayoon I; Siripanich H
    J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
    Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
    J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.